Clinical trial · Interventional
Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer
NCT05599698CI-TRIAL-00077127unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine changes in perceived daily performance and executive functioning following chemotherapy in individuals with non-central nervous system cancers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- chemotherapy
- description
- chemotherapy
- interventionNames
- Other: Chemotherapy
Primary outcomes (1)
- measure
- Change in scores of Canadian Occupational Performance Measure.
- timeFrame
- Change between Pre-to post (three months) chemotherapy
- description
- Canadian Occupational Performance Measure - COPM assesses perceived daily performance and performance satisfaction with meaningful daily activities. During the pre-chemotherapy assessment, participants will identify up to five activities that they prioritize as meaningful for them. Each of these activities is then rated on a 10-point scale for perceived performance (1=not able to do at all, 10=able to do extremely well) and similarly for satisfaction with performance. The final scores of the COPM are the average scores for total performance and for satisfaction (higher scores indicate better performance or satisfaction with performance). During the post-chemotherapy assessment, the participants will rate the same activities they prioritized in the pre-chemotherapy assessment.
Secondary outcomes (10)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed with a primary non-central nervous system malignancy (lung, breast, colon, ulcer, urinary tract, canine tumors). * Stages I-III. * Pre-commencement of adjuvant (post-surgery) or neoadjuvant (prior to surgery) chemotherapy. * Understand and read Hebrew. * Have at least 12 years of education. Exclusion Criteria: * Diagnosed with central nervous system malignancies. * Had a previous malignancy. * Have or had metastatic disease. * Have a history of a neurological condition or severe depression.
References
Publications (0)
Data not yet available
No reference posted for this study.